US Patent Issued to Stealth BioTherapeutics on Sept. 2 for "Mitochondria-targeting peptides" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,300, issued on Sept. 2, was assigned to Stealth BioTherapeutics Inc. (Needham, Mass.).

"Mitochondria-targeting peptides" was invented by Guozhu Zheng (Lexington, Mass.), Mark J. Bamberger (South Glastonbury, Conn.) and Inese Smukste (Weston, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are analogs of SBT-20. The compounds are useful for the treatment and prevention of ischemia-reperfusion injury (e.g., cardiac ischemia-reperfusion injury) or myocardial infarction."

The patent was filed on Nov. 19, 2019, under Application No. 17/414,103.

*For further information, including images, charts and tables, please visit: http://patft.uspt...